Company Update (NYSE:MS): JINTIAN PHARM (02211.HK) Kept "Overweight" with the Price Target Raised to $4.5 by Morgan Stanley

[ACN Newswire] – Hong Kong, Sept 18, 2014 – (ACN Newswire) – Morgan Stanley raised price target of Jintian Pharmaceutical (2211.HK) from HK$3.9 to HK$4.5 on higher distribution sales growth outlook and margin . . . → Read More: Company Update (NYSE:MS): JINTIAN PHARM (02211.HK) Kept "Overweight" with the Price Target Raised to $4.5 by Morgan Stanley Similar Articles: Stock Update (NASDAQ:QCOM): Qualcomm price target raised to $89 from $83 at Brean Capital Company Update (NYSE:C): Citigroup’s leaders say company needs to simplify itself Stock Update: Qualcomm Incorporated (NASDAQ:QCOM) – Qualcomm price target raised to $90 from $82 at CLSA